Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Recent insights into the mechanism of action of glatiramer acetate.
BRIEF: Teva files for Copaxone-Laquinimod patent
Reassessing the risk of natalizumab-associated PML.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Neurovascular and Immuno-Imaging Symposium
Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Novartis announces Russian regulatory approval for Gilenya®, a once-daily oral multiple sclerosis therapy and first in a new class
American Academy of Neurology Annual Meeting
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Characterization and quantitation of aggregates and particles in interferon-β products: Potential links between product quality attributes and immunogenicity.
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
National MS Society: Patient Management, Care and Rehabilitation Research Grants
Rebif approval application
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Fatigue and Comorbidities in Multiple Sclerosis.
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
Multiple Sclerosis: An Update.
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis

Pages